BlackRock Fund Advisors’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q4	$7.13M	Buy	648,924 +91,073	+16%	+$1M	﹤0.01%	2760
2016 Q3	$8.75M	Buy	557,851 +30,603	+6%	+$480K	﹤0.01%	2546
2016 Q2	$5.39M	Buy	527,248 +330,966	+169%	+$3.38M	﹤0.01%	2760
2016 Q1	$2.53M	Sell	196,282 -10,644	-5%	-$137K	﹤0.01%	3008
2015 Q4	$4.32M	Buy	+206,926	New	+$4.32M	﹤0.01%	2910